Sure, but their sales pitch and what it actually achieves might be two completely different things.
I guess what i would have preferred to have seen is the CEO talking up the efficiency and labor costs component and then reporting any fertility treatment benefits that the trials showed. ie, undersell and then over deliver.
As it turns out, the trials may very well show that their claims prove to be true in which case that would be brilliant. I am just hopeful that the market doesnt over-react negatively if the device shows that it is no worse than the current method but much faster/cheaper. Hope that makes sense.
MEM Price at posting:
3.8¢ Sentiment: None Disclosure: Held
